GnRH-a for Ovarian Protection During CYC Therapy for Rheumatic Diseases (LUPRON)
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
A PHASE3 clinical study on Isolated Angiitis of Central Nervous System and Lung Disease Interstitial Diffuse, this trial is terminated or withdrawn. The trial is conducted by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and has accumulated 9 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE3
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE3
-
Jan 2021 — Dec 2022 [monthly]
Terminated PHASE3
▶ Show 4 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE3
-
Aug 2017 — Jun 2018 [monthly]
Terminated PHASE3
-
Feb 2017 — Aug 2017 [monthly]
Terminated PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE3
First recorded
May 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Joseph Mccune
- National Institutes of Health (NIH)
For direct contact, visit the study record on ClinicalTrials.gov .